
12 Panel CLIA Waived Magenta Dip Card
12-panel urine dip card screening for Amphetamine, Barbiturates, Buprenorphine, and 9 more. Manufacturer SKU MGDDOA-6125.
Volume Pricing
| Quantity | Unit Price |
|---|---|
| 1–4 packs25–100 testsCurrent | $2.66/test |
| 5–20 packs125–500 tests | $2.46/test |
| 21–80 packs525–2,000 tests | $2.28/test |
| 81+ packs2,025+ tests | $2.09/test |
Quantity (packs)
Add 4 more packs to unlock $2.46/test
- Ships today if ordered by 3pm ET
- 30-day satisfaction guarantee
- Bulk pricing available — request a quote
12 Panel CLIA Waived Magenta Dip Card is a 12-panel urine dip card from Magenta (manufacturer SKU MGDDOA-6125). It screens for Amphetamine, Barbiturates, Buprenorphine, and 9 more in a single device, with each analyte and cutoff drawn directly from the manufacturer's panel specification.
The device tests for the following 12 analytes at the cutoffs printed on the package insert:
- Amphetamine (AMP): 1000 ng/mL
- Barbiturates (BAR): 300 ng/mL
- Buprenorphine (BUP): 10 ng/mL
- Benzodiazepines (BZO): 300 ng/mL
- Cocaine (COC): 300 ng/mL
- Methamphetamine (MET): 1000 ng/mL
- Ecstasy (MDMA): 500 ng/mL
- Morphine / Opiates (MOP): 300 ng/mL
- Methadone (MTD): 300 ng/mL
- Oxycodone (OXY): 100 ng/mL
- Phencyclidine (PCP): 25 ng/mL
- Marijuana (THC): 50 ng/mL
On this dip card, the individual test strips are housed in a durable plastic cartridge that holds them at a fixed position during collection. The collector dips the cartridge to the indicated MAX line, lays the device flat, and reads the result window once it has fully developed.
Per the manufacturer SKU line in the owner's catalog, this device is labeled CLIA-Waived / FDA / OTC — suitable for moderate-complexity workplace, clinical, and behavioral-health screening programs operating under CLIA-waived certification.
Typical buyers are behavioral-health clinicians, substance-use treatment programs, criminal justice supervision programs, and harm-reduction organizations that need single-analyte or low-panel screens against an already-collected urine sample.
Dip cards are typically chosen by programs that already have a separate collection container — for example, a behavioral-health clinician using a standard specimen cup at intake and then running a low-panel screen against the same sample. When comparing dip cards across vendors, look at the cartridge construction (a sturdy cartridge that holds the strips at a fixed immersion depth reduces wicking errors), the analyte-to-cutoff combinations available, and whether your bulk-purchase tier qualifies for case-pack pricing versus unit pricing.
Magenta reserves the right to substitute with a comparable branded product when backordered.
Manufacturer SKU: MGDDOA-6125. Always read the lot number, expiration date, and proper read window from the package insert that ships with the device.
About the 12 Panel CLIA Waived Magenta Dip Card
12 Panel CLIA Waived Magenta Dip Card is a 12-panel urine dip card from Magenta (manufacturer SKU MGDDOA-6125). It screens for Amphetamine, Barbiturates, Buprenorphine, and 9 more in a single device, with each analyte and cutoff drawn directly from the manufacturer's panel specification.
The device tests for the following 12 analytes at the cutoffs printed on the package insert:
- Amphetamine (AMP): 1000 ng/mL
- Barbiturates (BAR): 300 ng/mL
- Buprenorphine (BUP): 10 ng/mL
- Benzodiazepines (BZO): 300 ng/mL
- Cocaine (COC): 300 ng/mL
- Methamphetamine (MET): 1000 ng/mL
- Ecstasy (MDMA): 500 ng/mL
- Morphine / Opiates (MOP): 300 ng/mL
- Methadone (MTD): 300 ng/mL
- Oxycodone (OXY): 100 ng/mL
- Phencyclidine (PCP): 25 ng/mL
- Marijuana (THC): 50 ng/mL
On this dip card, the individual test strips are housed in a durable plastic cartridge that holds them at a fixed position during collection. The collector dips the cartridge to the indicated MAX line, lays the device flat, and reads the result window once it has fully developed.
Per the manufacturer SKU line in the owner's catalog, this device is labeled CLIA-Waived / FDA / OTC — suitable for moderate-complexity workplace, clinical, and behavioral-health screening programs operating under CLIA-waived certification.
Typical buyers are behavioral-health clinicians, substance-use treatment programs, criminal justice supervision programs, and harm-reduction organizations that need single-analyte or low-panel screens against an already-collected urine sample.
Dip cards are typically chosen by programs that already have a separate collection container — for example, a behavioral-health clinician using a standard specimen cup at intake and then running a low-panel screen against the same sample. When comparing dip cards across vendors, look at the cartridge construction (a sturdy cartridge that holds the strips at a fixed immersion depth reduces wicking errors), the analyte-to-cutoff combinations available, and whether your bulk-purchase tier qualifies for case-pack pricing versus unit pricing.
Magenta reserves the right to substitute with a comparable branded product when backordered.
Manufacturer SKU: MGDDOA-6125. Always read the lot number, expiration date, and proper read window from the package insert that ships with the device.
Related Products
Ships Today10 Panel CLIA Waived Magenta Dip Card
10-panel urine dip card screening for Amphetamine, Barbiturates, Buprenorphine, and 7 more. Manufacturer SKU MGDDOA-1105C.
Ships Today12 Panel + 3 Adulterants CLIA Waived Magenta Urine Cup
12-panel integrated urine cup screening for Amphetamine, Barbiturates, Buprenorphine, and 9 more. Manufacturer SKU MGDSDOA-6125A3.
Ships Today12 Panel Magenta Urine Cup
12-panel integrated urine cup screening for Amphetamine, Barbiturates, Buprenorphine, and 9 more. Manufacturer SKU MGDSDOA-6125.
Ships Today80 Hour ETG Alcohol Magenta Dip Card Flood Proof
Single-analyte urine dip card for Alcohol (EtG) at 300 ng/mL. Manufacturer SKU MGDD-ETG300.
Trusted by